Researchers made a significant advance in understanding Alzheimer's disease (AD) by pinpointing how specific brain cells contribute to different stages of the disease. Employing single nucleus RNA sequencing, they analyzed genetic risks in microglia and astrocytes, revealing distinct roles these cells play in AD progression.